Summary
Overview
Work History
Education
Skills
Timeline
Generic

Tomasz Boruch

Rye Brook,USA

Summary

Accomplished executive with extensive experience at AstraZeneca, specializing in strategic negotiation and developing high-performing teams. Expertly led market access initiatives that resulted in substantial revenue growth and increased market share. Renowned for analytical decision-making capabilities and exceptional stakeholder relationship management, consistently achieving outstanding sales performance and operational efficiency.

Overview

27
27
years of professional experience

Work History

Director – Portfolio Contract Strategy, FARXIGA/BRILINTA

AstraZeneca
Wilmington, DE
08.2022 - Current
  • Responsible for developing negotiation pathways that deliver net price and access aligned with quarterly and annual budgets for CVRM brands across all Market Access customer types and business segments
  • Leadership position on critical initiatives including but not limited to IRA (Redesign/MFP), Amp CAP, MDRP Stacking, LOEs, authorized generics
  • Created and secured new FARXIGA standard contract offer which significantly increased efficiency of RFP process and secured access within approved GOA
  • Overhauled pricing rubric for BRILINTA which resulted in price appreciation across Medicaid, VA, DOD and exceeding of annual budget
  • Initiated and led review of IVS contracts for BRILINTA which resulted in cancellation of underperforming agreements while retaining access
  • US market access lead for developing pre-launch planning for Farxiga Authorized Generic which resulted in early launch and channel readiness
  • Exceeded 2023 net price and access levels aligned with annual forecast for BRILINTA and FARXIGA and on track to exceed 2024 goals
  • Negotiated Farxiga deal at Select Health estimated to produce ~$14M in incremental revenue

Director – Market Access Strategy, BRILINTA/BCISE

AstraZeneca
Wilmington, DE
01.2022 - 07.2022
  • Exceeded 2022 net price and access level aligned with annual forecast for BRILINTA while decreasing affordability gross to net through affordability optimization and profitable contract negotiations
  • Created and delivered comprehensive forecasting model which provided Sr
  • Leadership with stronger insight during short- and long-term brand planning cycles
  • Optimized BCISE and BRILINTA affordability year over year to increase product sales contribution in line with brand strategy
  • As lead for CVRM, partnered with Access Services to develop and socialize Accumulator Law mitigation options and financial impacts
  • Led and delivered aligned LOE strategy plan for BRILINTA in consultation with brand, global, and finance teams

Associate Director – Market Access Strategy, BYDUREON

AstraZeneca
Wilmington, DE
08.2019 - 12.2021
  • Created and led implementation of significant product discontinuation/switch plan across market access, channel and payer teams that exceeded product switch stretch goals set by TA leadership
  • CVMD Market access lead responsible for researching, aligning, and delivering US market strategic forecast to global marketing team for Phase 3 early development drug candidates
  • Created and gained approval for the first Farxiga high deductible program which resulted in incremental Trx’s, positive net sales, and reduced abandonment rates
  • Optimized affordability programs for both Farxiga and BYDUREON family, which offset rate increases and contributed to positive net product sales for FY2020 (-$46MM-Farxiga, -$20MM-Bydureon)
  • Partnered with regional payer team to build business case and secure first BCISE access win in two years
  • Partnered with channel team to implement the first BYDUREON patient adherence program which has resulted in increased patient persistency of 1.5 Trx/patient
  • As lead for market access, built cross TA team to create and launch a six-month virtual development series for CVMD in house employees focusing on topics of innovation and creativity

Commercial Business Director – Diabetes

AstraZeneca
Wilmington, DE
05.2012 - 07.2019
  • Field lead for Organized Customer Accounts Group – worked to refine and standardize Heath System strategy across TA’s
  • Led cross TA team to strengthen pull through with CDPHP in Albany resulting in 70% FARXIGA market share after CVS Caremark formulary change
  • FARXIGA CBD Brand Point – Refined strategy via war games, analysis of market research, as well as direct feedback of field intelligence in pre-launch meetings with brand
  • National CBD lead for developing and implementing innovative coaching and selling model utilizing artificial intelligence
  • Promoted three managers and four representatives to specialty and home office positions
  • 2015 Circle of Excellence Award - #1 Region in Nation
  • 2017 #5 Region in Nation
  • 2019 #2 Region in Nation

Regional Director – Northeast Sales

Amylin Pharmaceuticals
San Diego, CA
05.2011 - 05.2012
  • Responsible for achieving and exceeding one quarter of company sales forecasts totaling $150MM
  • Developed and implemented coordinated business plans with team of integrated business partners in Managed Markets, Medical, and Professional Education
  • Sales lead on project to revamp and update Amylin’s performance management process which resulted in step change in sales achievement
  • 2011 NYC District Amylin Elite Award - #2 District in nation

Associate Director – Sales / Senior District Manager

Amylin Pharmaceuticals
San Diego, CA
03.2005 - 05.2011
  • Managed and developed four Principal DSS’s and three District Managers from Senior DSS positions
  • Responsible for interviewing and hiring 50% of Northeast Region sales positions during initial expansion
  • Led a cross functional team of IBT, Lilly, and Amylin members to develop strategic and tactical plans which successfully overturned the prior authorization of BYETTA on New York State Medicaid PDL
  • Exceeds Expectations achieved on six of seven performance appraisals with cultural beliefs consistently rated Exceeds or higher
  • 2006 Regional Elite Winner - #1district in region
  • 2009 Amylin Elite Winner - #4 district in nation

Specialty Territory Manager

Amylin Pharmaceuticals
San Diego, CA
11.2003 - 03.2005
  • Won Shining Star Award at primary training as voted on by peers
  • 2005 - Amylin Elite winner - #4 territory in nation

Account Manager

Liposcience Inc.
Raleigh, NC
06.2001 - 11.2003
  • Marketed novel cardiovascular risk assessment to cardiologists, endocrinologists, and internists

Cardiovascular-Metabolic Sales Specialist (Hospital Division)

Novartis Pharmaceuticals
East Hanover, NJ
12.2000 - 05.2001
  • Awarded “stocked” status for STARLIX at three of five hospitals within two months of launch

Sales Consultant, Novartis III Field Sales Force

Novartis Pharmaceuticals
East Hanover, NJ
02.1998 - 11.2000
  • Presidents Club and District of the Year Awards, 2000
  • Won four Directors Awards for outstanding sales performance

Education

B.S. - Finance

Binghamton University
01.1994

Skills

  • Strategic Negotiation Skills
  • Analytical Decision-Making
  • Market analysis
  • Team Leadership Development
  • Stakeholder Relationship Management
  • Tactical Strategy Formulation

Timeline

Director – Portfolio Contract Strategy, FARXIGA/BRILINTA

AstraZeneca
08.2022 - Current

Director – Market Access Strategy, BRILINTA/BCISE

AstraZeneca
01.2022 - 07.2022

Associate Director – Market Access Strategy, BYDUREON

AstraZeneca
08.2019 - 12.2021

Commercial Business Director – Diabetes

AstraZeneca
05.2012 - 07.2019

Regional Director – Northeast Sales

Amylin Pharmaceuticals
05.2011 - 05.2012

Associate Director – Sales / Senior District Manager

Amylin Pharmaceuticals
03.2005 - 05.2011

Specialty Territory Manager

Amylin Pharmaceuticals
11.2003 - 03.2005

Account Manager

Liposcience Inc.
06.2001 - 11.2003

Cardiovascular-Metabolic Sales Specialist (Hospital Division)

Novartis Pharmaceuticals
12.2000 - 05.2001

Sales Consultant, Novartis III Field Sales Force

Novartis Pharmaceuticals
02.1998 - 11.2000

B.S. - Finance

Binghamton University
Tomasz Boruch